Kain Lawyers is proud to have advised Atmo Biosciences on the investment by Breakthrough Victoria. This investment will support the commercialization of the Atmo Biosciences’ world-first ingestible gas-sensing capsule that can help diagnose functional gastrointestinal disorders, which affect almost 40% of Australians. Atmo Biosciences CEO Malcolm Hebblewhite said he was delighted to welcome Breakthrough Victoria as a long-term, strategic investor. The Kain Lawyers deal team was led by Alyce Ricciardi and Gerry Cawson with assistance from Dan Wood. Congratulations to all involved. #transactionspecialists
